Published by Josh White on 19th January 2023
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics said in an update on Thursday that its financial performance for 2022 was in line with market expectations, as it closed the period with an unaudited cash balance of £12.8m.
URL: http://www.digitallook.com/dl/news/story/33248079/...